-
1
-
-
0023200888
-
Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program
-
Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 1987; 36: 689-692.
-
(1987)
Diabetes
, vol.36
, pp. 689-692
-
-
Donahue, R.P.1
Abbott, R.D.2
Reed, D.M.3
Yano, K.4
-
2
-
-
0020031051
-
The Bedford survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics
-
Jarrett RJ, McCartney P, Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
-
(1982)
Diabetologia
, vol.22
, pp. 79-84
-
-
Jarrett, R.J.1
McCartney, P.2
Keen, H.3
-
3
-
-
0018341014
-
Diabetes and cardiovascular risk factors: The Framingham study
-
Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59: 8-13.
-
(1979)
Circulation
, vol.59
, pp. 8-13
-
-
Kannel, W.B.1
McGee, D.L.2
-
4
-
-
0025292357
-
Prevalence of asymptomatic myocardial ischaemia in diabetic subjects
-
Koistinen MJ, Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990; 301: 92-95.
-
(1990)
Br Med J
, vol.301
, pp. 92-95
-
-
Koistinen, M.J.1
-
5
-
-
0027984808
-
Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
-
Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacological Reviews 1994; 46: 325-415.
-
(1994)
Pharmacological Reviews
, vol.46
, pp. 325-415
-
-
Rubanyi, G.M.1
Polokoff, M.A.2
-
6
-
-
0027372832
-
The role of endothelin in the vessel wall
-
Chabrier PE. The role of endothelin in the vessel wall. Baillières Clin Haematol 1993; 6: 577-591.
-
(1993)
Baillières Clin Haematol
, vol.6
, pp. 577-591
-
-
Chabrier, P.E.1
-
7
-
-
0021345582
-
Conversion of angiotensin I to angiotensin II and inactivation of bradykinin in canine peripheral vascular beds
-
Suzuki M, Ohyama Y, Satoh S. Conversion of angiotensin I to angiotensin II and inactivation of bradykinin in canine peripheral vascular beds. J Cardiovasc Pharmacol 1984; 6: 244-250.
-
(1984)
J Cardiovasc Pharmacol
, vol.6
, pp. 244-250
-
-
Suzuki, M.1
Ohyama, Y.2
Satoh, S.3
-
8
-
-
0025221768
-
Cellular signaling by peptides of the endothelin gene family
-
Simonson MS, Dunn MJ. Cellular signaling by peptides of the endothelin gene family. FASEB J 1990; 4: 2989-3000.
-
(1990)
FASEB J
, vol.4
, pp. 2989-3000
-
-
Simonson, M.S.1
Dunn, M.J.2
-
9
-
-
0027377197
-
The vascular endothelium. A new horizon
-
Davies MG, Hagen PO. The vascular endothelium. A new horizon. Annals of Surgery 1993; 218: 593-609.
-
(1993)
Annals of Surgery
, vol.218
, pp. 593-609
-
-
Davies, M.G.1
Hagen, P.O.2
-
10
-
-
0025940245
-
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis
-
Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC, Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
-
(1991)
N Engl J Med
, vol.325
, pp. 997-1001
-
-
Lerman, A.1
Edwards, B.S.2
Hallett, J.W.3
Heublein, D.M.4
Sandberg, S.M.5
Burnett Jr., J.C.6
-
11
-
-
0023198721
-
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
-
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
-
(1987)
Nature
, vol.327
, pp. 524-526
-
-
Palmer, R.M.1
Ferrige, A.G.2
Moncada, S.3
-
12
-
-
0023518452
-
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical
-
lgnarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical, Circ Res 1987; 61: 866-879.
-
(1987)
Circ Res
, vol.61
, pp. 866-879
-
-
Lgnarro, L.J.1
Byrns, R.E.2
Buga, G.M.3
Wood, K.S.4
-
13
-
-
0023912670
-
Vascular endothelial cells synthesize nitric oxide from L-arginine
-
Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
-
(1988)
Nature
, vol.333
, pp. 664-666
-
-
Palmer, R.M.1
Ashton, D.S.2
Moncada, S.3
-
14
-
-
0029128672
-
The role of nitric oxide and other endothel iumderived vasoactive substances in vascular disease
-
Cohen RA. The role of nitric oxide and other endothel iumderived vasoactive substances in vascular disease. Prog Cardiovas Dis 1995; 38: 105-128.
-
(1995)
Prog Cardiovas Dis
, vol.38
, pp. 105-128
-
-
Cohen, R.A.1
-
15
-
-
0027529593
-
Mechanical stress mechanisms and the cell. An endothelial paradigm
-
Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell. An endothelial paradigm. Circ Res 1993; 72: 239-245.
-
(1993)
Circ Res
, vol.72
, pp. 239-245
-
-
Davies, P.F.1
Tripathi, S.C.2
-
16
-
-
0028907739
-
Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases
-
Loskove JA, Frishman WH. Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases. Am Heart J 1995; 129: 604-613.
-
(1995)
Am Heart J
, vol.129
, pp. 604-613
-
-
Loskove, J.A.1
Frishman, W.H.2
-
17
-
-
0028296939
-
Termination of endothelin signaling: Role of nitric oxide
-
Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF. Termination of endothelin signaling: role of nitric oxide. Journal of Cellular Physiology 1994; 158: 485-494.
-
(1994)
Journal of Cellular Physiology
, vol.158
, pp. 485-494
-
-
Goligorsky, M.S.1
Tsukahara, H.2
Magazine, H.3
Andersen, T.T.4
Malik, A.B.5
Bahou, W.F.6
-
18
-
-
0028180139
-
Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells
-
Prins BA, Hu RM, Nazario B, Pedram A, Frank HJ, Weber MA, et al. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269: 11938-11944.
-
(1994)
J Biol Chem
, vol.269
, pp. 11938-11944
-
-
Prins, B.A.1
Hu, R.M.2
Nazario, B.3
Pedram, A.4
Frank, H.J.5
Weber, M.A.6
-
19
-
-
0025950298
-
Endothelium and growth factors in vascular remodeling of hypertension
-
Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension 1991; 18 (suppl III): 115-121.
-
(1991)
Hypertension
, vol.18
, Issue.3 SUPPL.
, pp. 115-121
-
-
Dzau, V.J.1
Gibbons, G.H.2
-
20
-
-
0030005626
-
Role of endothelium in thrombosis and hemostasis
-
Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annual Review of Medicine 1996; 47: 315-331.
-
(1996)
Annual Review of Medicine
, vol.47
, pp. 315-331
-
-
Wu, K.K.1
Thiagarajan, P.2
-
21
-
-
0028111208
-
Endothelial cell function and thrombosis
-
Pearson JD. Endothelial cell function and thrombosis. Baillières Clin Haematol 1994; 7: 441-452.
-
(1994)
Baillières Clin Haematol
, vol.7
, pp. 441-452
-
-
Pearson, J.D.1
-
22
-
-
0027179089
-
Willebrand factor: Structure and function
-
Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70: 99-104.
-
(1993)
Thromb Haemost
, vol.70
, pp. 99-104
-
-
Meyer, D.1
Von Girma, J.P.2
-
24
-
-
0025948224
-
Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
-
Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-355.
-
(1991)
Br Heart J
, vol.66
, pp. 351-355
-
-
Jansson, J.H.1
Nilsson, T.K.2
Von Johnson, O.3
-
25
-
-
0029028967
-
Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in athero-sclerosis
-
Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in athero-sclerosis. Thrombosis & Haemostasis 1995; 74: 626-630.
-
(1995)
Thrombosis & Haemostasis
, vol.74
, pp. 626-630
-
-
Blann, A.D.1
Dobrotova, M.2
Kubisz, P.3
Von McCollum, C.N.4
-
26
-
-
1842286547
-
Elevated von Willebrand factor (vWF): An independent risk factor for cerebrovascular mortality
-
Catto AJ, Carter AM, Barrett JH, Boothby M, Bamford J, Grant PJ. Elevated von Willebrand factor (vWF): an independent risk factor for cerebrovascular mortality. (Abstract) Blood Coagul Fibrinolysis 1995; 6: 590.
-
(1995)
(Abstract) Blood Coagul Fibrinolysis
, vol.6
, pp. 590
-
-
Catto, A.J.1
Carter, A.M.2
Barrett, J.H.3
Boothby, M.4
Bamford, J.5
Grant, P.J.6
-
27
-
-
0027209683
-
Factor VIII structure and function
-
Fay PJ. Factor VIII structure and function. Thromb Haemost 1993; 70: 63-67.
-
(1993)
Thromb Haemost
, vol.70
, pp. 63-67
-
-
Fay, P.J.1
-
28
-
-
0025953551
-
Platelet activation in the pathogenesis of unstable angina: Importance in determining the response to plasminogen activators
-
Fitzgerald DJ. Platelet activation in the pathogenesis of unstable angina: importance in determining the response to plasminogen activators. Am J Cardiol 1991; 68: 51B-57B.
-
(1991)
Am J Cardiol
, vol.68
-
-
Fitzgerald, D.J.1
-
30
-
-
0028500165
-
Stabilization of platelet-fibrinogen interactions is an integral property of the glycoprotein IIb-IIIa complex
-
Peerschke EI. Stabilization of platelet-fibrinogen interactions is an integral property of the glycoprotein IIb-IIIa complex. J Lab Clin Med 1994; 124: 439-446.
-
(1994)
J Lab Clin Med
, vol.124
, pp. 439-446
-
-
Peerschke, E.I.1
-
31
-
-
0028901881
-
Fibrinogen in human atherosclerosis
-
Bini A, Kudryk BJ. Fibrinogen in human atherosclerosis. Ann NY Acad Sci 1995; 748: 461-471.
-
(1995)
Ann NY Acad Sci
, vol.748
, pp. 461-471
-
-
Bini, A.1
Kudryk, B.J.2
-
32
-
-
0030899786
-
Gender specific associations of the fibrinogen Bb 448 polymor-phism, fibrinogen levels and acute cerebrovascular disease
-
Carter AM, Catto AJ, Bamford JM, Grant PJ. Gender specific associations of the fibrinogen Bb 448 polymor-phism, fibrinogen levels and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 589-594.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 589-594
-
-
Carter, A.M.1
Catto, A.J.2
Bamford, J.M.3
Grant, P.J.4
-
33
-
-
0022485106
-
Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
-
Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
-
(1986)
Lancet
, vol.2
, pp. 533-537
-
-
Meade, T.W.1
Mellows, S.2
Brozovic, M.3
Miller, G.J.4
Chakrabarti, R.R.5
North, W.R.6
-
34
-
-
0028127942
-
Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men
-
Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo JC. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men, Arter Thromb 1994; 14: 54-59.
-
(1994)
Arter Thromb
, vol.14
, pp. 54-59
-
-
Heinrich, J.1
Balleisen, L.2
Schulte, H.3
Assmann, G.4
Van De Loo, J.C.5
-
35
-
-
0021210911
-
Fibrinogen as a risk factor for stroke and myocardial infarction
-
Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505.
-
(1984)
N Engl J Med
, vol.311
, pp. 501-505
-
-
Wilhelmsen, L.1
Svärdsudd, K.2
Korsan-Bengtsen, K.3
Larsson, B.4
Welin, L.5
Tibblin, G.6
-
36
-
-
0027125530
-
The pathogenesis of coronary artery disease and the acute coronary syndromes
-
Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250.
-
(1992)
N Engl J Med
, vol.326
, pp. 242-250
-
-
Fuster, V.1
Badimon, L.2
Badimon, J.J.3
Chesebro, J.H.4
-
37
-
-
0025896795
-
Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
-
Cybulsky MI, Gimbrone MA, Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251: 788-791.
-
(1991)
Science
, vol.251
, pp. 788-791
-
-
Cybulsky, M.I.1
Gimbrone Jr., M.A.2
-
38
-
-
0029012903
-
Leukocyte adhesion molecules
-
Chapman PT, Haskard DO. Leukocyte adhesion molecules. Br Med Bull 1995; 51: 296-311.
-
(1995)
Br Med Bull
, vol.51
, pp. 296-311
-
-
Chapman, P.T.1
Haskard, D.O.2
-
39
-
-
0028338958
-
Role of selectins in leukocyte adhesion to platelets and endothelium
-
McEver RP. Role of selectins in leukocyte adhesion to platelets and endothelium. Ann NY Acad Sci 1994; 714: 185-189.
-
(1994)
Ann NY Acad Sci
, vol.714
, pp. 185-189
-
-
McEver, R.P.1
-
40
-
-
0027935309
-
Leukocyte-endothelial adhesion molecules
-
Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
-
(1994)
Blood
, vol.84
, pp. 2068-2101
-
-
Carlos, T.M.1
Harlan, J.M.2
-
41
-
-
0029143965
-
Increased soluble form of P-selectin in patients with unstable angina
-
Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92: 1693-1696.
-
(1995)
Circulation
, vol.92
, pp. 1693-1696
-
-
Ikeda, H.1
Takajo, Y.2
Ichiki, K.3
Ueno, T.4
Maki, S.5
Noda, T.6
-
42
-
-
8544251650
-
-
Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA
-
Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA,
-
-
-
|